Lifecore seeks US approval for anti-adhesion gel:
This article was originally published in Clinica
Lifecore Biomedical has filed a premarket approval application with the FDA for its Intergel solution for preventing post-operative adhesions. The fifth and final module of the application, submitted earlier this month, contains an analysis of data from a clinical trial of the ferric hyaluronate product involving over 265 women who underwent intraperitoneal laparotomy procedures, said the Chaska, Minnesota-based company. The product is currently marketed in Europe by the Gynecare Division of Ethicon, a Johnson & Johnson company.